Chemed Corporation
CHE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $624,900 | $618,798 | $646,943 | $639,993 |
| % Growth | 1% | -4.4% | 1.1% | – |
| Cost of Goods Sold | $444,227 | $434,105 | $430,530 | $405,875 |
| Gross Profit | $180,673 | $184,693 | $216,413 | $234,118 |
| % Margin | 28.9% | 29.8% | 33.5% | 36.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $105,775 | $99,405 | $105,587 | $104,251 |
| SG&A Expenses | $105,775 | $99,405 | $105,587 | $104,251 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $17,204 | $16,068 | $15,989 |
| Operating Expenses | $105,775 | $116,609 | $121,655 | $120,240 |
| Operating Income | $74,750 | $68,084 | $94,758 | $113,878 |
| % Margin | 12% | 11% | 14.6% | 17.8% |
| Other Income/Exp. Net | $8,794 | $3,031 | $916 | $6,245 |
| Pre-Tax Income | $83,544 | $71,115 | $95,674 | $120,123 |
| Tax Expense | $19,307 | $18,622 | $23,917 | $29,804 |
| Net Income | $64,237 | $52,493 | $71,757 | $90,319 |
| % Margin | 10.3% | 8.5% | 11.1% | 14.1% |
| EPS | 4.46 | 3.6 | 4.91 | 6.08 |
| % Growth | 23.9% | -26.7% | -19.2% | – |
| EPS Diluted | 4.46 | 3.57 | 4.86 | 6.02 |
| Weighted Avg Shares Out | 14,535 | 14,606 | 14,622 | 14,853 |
| Weighted Avg Shares Out Dil | 14,535 | 14,606 | 14,764 | 14,992 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,631 | $2,555 | $2,076 | $3,205 |
| Interest Expense | $2,001 | $443 | $329 | $499 |
| Depreciation & Amortization | $16,234 | $16,260 | $16,017 | $15,831 |
| EBITDA | $101,779 | $87,818 | $112,020 | $136,453 |
| % Margin | 16.3% | 14.2% | 17.3% | 21.3% |